NEUPOGEN

Swiss trademark · 392611 · Word mark · In force

Register entry

Registration number
392611
Application number
06028/1991
Status
In force
Type
Word mark
Filed
Sep 2, 1991
Registered
May 22, 1992
Published
Jun 25, 1992
Protected until
Sep 2, 2031
Remarks
Hinterlegung Erneuerungsmarke: 02.09.1991Dépôt de la marque renouvelée: 02.09.1991Deposito del marchio prorogato: 02.09.1991 mit abgeänderter Warenangabe
Renews
367942
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, nämlich rekombinante Human-Granulozyten-CSF zur Stimulierung der Produktion von weissen Blutkörperchen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 18, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 18.12.2023

  2. Aug 24, 2021

    Renewed

    Published in Swissreg on 24.08.2021

  3. May 16, 2011

    Holder’s address changed

    Owner
    Amgen Inc., Amgen Center, 1840 Dehavilland Drive, Thousand Oaks (CA 91320-1789), USA → Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA

    Published in Swissreg on 16.05.2011

  4. May 16, 2011

    Renewed

    Published in Swissreg on 16.05.2011

  5. Dec 17, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 244 of 17.12.2007

  6. Jun 25, 1992

    Registered

    Published in the SOGC no. 120 of 25.06.1992

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.